Ocrelizumab (Ocrevus)

Indications

  • xxx

Pharmacology

  • Humanized (90%-95% Human) Monoclonal Anti-CD20 Antibody (see Anti-CD20 Therapy, [[Anti-CD20 Therapy]]): present on B-cells -> results in B-cell depletion

Metabolism

  • xxxx

Administration

  • xxxx

Dose Adjustment

  • Hepatic:
  • Renal:

Adverse Effects

Other Adverse Effects

  • xxx
  • xxx
  • xxx

References

  • xxxx